by Elena Iemma | Sep 22, 2023
Innovative Preclinical Assessment Tools for Safety and Efficacy of Protein and Peptide Therapeutics… of Peptides and P-ANDAS
by Elena Iemma | Sep 21, 2023
Prospectively Assessing the Immunogenic Risk of Potential Synthetic Peptide Impurities in silico with the What-if Machine (WhIM)
by Annie De Groot | Sep 23, 2020
Addressing Immunogenicity of Observed and Theoretical Impurities for Peptide Abbreviated New Drug Applications